• Announcing a New Online Tool for the DIFICID® Co-Pay Assistance Program

    Eligible patients* can now answer 7 questions online to be pre-qualified for a DIFICID Co-Pay Coupon that can be used in a Retail Pharmacy. With this coupon, eligible patients* can save up to $200 off their out of pocket costs for a single DIFICID prescription.

    LEARN MORE

    *Restrictions and Conditions Apply

  • DIFICID® (fidaxomicin) tablets Granted New Technology Add-On Payment (NTAP)

    Centers for Medicare & Medicaid Services has granted a NTAP for DIFICID administered in the impatient hospital setting to treat Clostridium difficile-associated diarrhea (CDAD)*

    READ MORE

Welcome to DIFICIDDischarge.com: Helping discharge planners
help their patients with Clostridium difficile-associated diarrhea (CDAD)

What are DIFICID® (fidaxomicin) tablets?

DIFICID is the first FDA-approved bactericidal therapy in more than 25 years that targets C. difficileClostridium difficile (klos-TRID-e-uhm dif-uh-SEEL), often called C. difficile or C. diff, is spore-forming..., indicated in adults aged ≥18 years for the treatment of CDAD. DIFICID is a 200 mg oral tablet that acts locally in the gastrointestinal tract to fight C. difficile.

For more information, visit www.DIFICID.com

Important Safety Information

  • DIFICID is contraindicated in patients with hypersensitivity to fidaxomicin
  • DIFICID should not be used for systemic infections
  • Acute hypersensitivity reactions (angioedema, dyspnea, pruritus, and rash) have been reported. In the event of a severe reaction, discontinue DIFICID.
  • Only use DIFICID for infection proven or strongly suspected to be caused by C. difficile.
    Prescribing DIFICID in the absence of a proven or strongly suspected C. difficile infection is unlikely to provide benefit to the patient and increases the risk of the development of drug- resistant bacteria.
  • The most common adverse reactions reported in clinical trials are nausea (11%), vomiting (7%), abdominal pain (6%), gastrointestinal hemorrhage (4%), anemia (2%), and neutropenia (2%)

Indication and Usage

  • DIFICID is a macrolide antibacterial drug indicated in adults ≥ 18 years of age for treatment of Clostridium difficile-
    associated diarrhea
  • To reduce the development of drug-resistant bacteria and maintain the effectiveness of DIFICID and other
    antibacterial drugs, DIFICID should be used only to treat infections that are proven or strongly suspected
    to be caused by Clostridium difficile

Please click here for full prescribing information for DIFICID